Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?
Spaeth
G L
GL
D000086:Acetazolamide / Q000009:adverse effects*; D000741:Anemia, Aplastic / Q000517:prevention & control*; D001772:Blood Cell Count; D006801:Humans; D008991:Monitoring, Physiologic; D012307:Risk Factors
D000086:Acetazolamide